Hypertension
Showing NaN - NaN of 152
Hypertension, Blood Pressure, Systolic Hypertension Trial in Seoul (CART-I Plus)
Recruiting
- Hypertension
- +6 more
- CART-I Plus
-
Seoul, Korea, Republic ofSeoul National Univesity Hospital
Oct 11, 2023
Hypertension, Diabetes, Type 2 Trial in Seoul (THP-00101 (Dapagliflozin) 10mg, THP-00102 (Telmisartan) 80mg)
Recruiting
- Hypertension
- Diabetes Mellitus, Type 2
- THP-00101 (Dapagliflozin) 10mg
- THP-00102 (Telmisartan) 80mg
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Sep 25, 2023
Hypertension Trial in Seoul (BR1015, BR1015-1, BR1015-2)
Not yet recruiting
- Hypertension
- BR1015
- +2 more
-
Seoul, Gwanakgu, Korea, Republic ofClinical Research Center, H PLUS Yangji Hospital
Aug 16, 2023
Hypertension Trial in Seoul (BR1015, BR1015-1, BR1015-2)
Active, not recruiting
- Hypertension
- BR1015
- +2 more
-
Seoul, Gwanakgu, Korea, Republic ofClinical Research Center, H PLUS Yangji Hospital
Aug 22, 2023
OLOMAX for Blood Pressure and Low-density Lipoprotein
Recruiting
- Hypertension
- Dyslipidemias
- Olmesartan Medoxomil/ Amlodipine Besylate/ Rosuvastatin Ca
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital
Dec 13, 2022
Aortic Stenosis, Aortic Regurgitation, Hypertension Trial in Seoul (Amlodipine 5mg, Losartan, Losartan and Amlodipine)
Completed
- Aortic Stenosis
- +4 more
- Amlodipine 5mg
- +4 more
-
Seoul, Korea, Republic of10 Institutions Including Asan Medical Center
Sep 13, 2022
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
Recruiting
- Hypertension
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Sep 7, 2022
Hypertension Trial in Seoul, Anyang, Seongnam (Mobile Application, Standard SMBP)
Completed
- Hypertension
- Mobile Application
- Standard SMBP
-
Seoul, Guro, Korea, Republic of
- +4 more
Aug 22, 2022
Hypertension, Vascular Diseases, Cardiovascular Diseases Trial in Korea, Republic of (Renal Denervation)
Recruiting
- Hypertension
- +2 more
- Renal Denervation
-
Bucheon, Korea, Republic of
- +29 more
Aug 16, 2022
Hypertension Trial in Seoul (HCP2102-1, HPP2104-1, HCP2102-2)
Recruiting
- Hypertension
- HCP2102-1
- +7 more
-
Seoul, Korea, Republic ofKyung Hee University Hospital
Jul 31, 2022
Effectiveness and Safety of Amosartan Q Tablet
Completed
- Hypertension
- Dyslipidemia
- Amosartan Q tablet
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Jul 5, 2022
Dyslipidemia, Hypertension Trial in Seoul (LivaloVA, LivaloV, VA)
Recruiting
- Dyslipidemia
- Hypertension
- LivaloVA
- +2 more
-
Seoul, Korea, Korea, Republic ofGangdong Sacred Heart Hospital
Apr 10, 2022
Hypertension Trial in Seoul (Nebivolol)
Active, not recruiting
- Hypertension
-
Seoul, Korea, Republic ofKorea University Anam Hospital
Apr 6, 2022
Dyslipidemias, Hypertension Trial in Seoul (ID140009, ID1803+ID1805)
Recruiting
- Dyslipidemias
- Hypertension
- ID140009
- ID1803+ID1805
-
Seoul, Korea, Republic ofH plus yangji hospital
Feb 17, 2022
Hypertension, Hyperlipidemias Trial in Seoul (Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg, Olmesartan 40
Completed
- Hypertension
- Hyperlipidemias
- Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
- +2 more
-
Seoul, Korea, Republic ofSeoul national university bundang hospital
Dec 20, 2021
Hypertension, Vascular Diseases Trial in Japan, Korea, Republic of (PRDS-001 Renal Denervation Ultrasound System, Sham
Completed
- Hypertension
- Vascular Diseases
- PRDS-001 Renal Denervation Ultrasound System
- Sham Procedure
-
Hirosaki, Aomori, Japan
- +52 more
Nov 11, 2021
Hypertension Trial in Seoul (C52R1M Tab. and C52R2 Tab., AJU-C52H)
Recruiting
- Hypertension
- C52R1M Tab. and C52R2 Tab.
- AJU-C52H
-
Seoul, Republic Of South Korea, Korea, Republic ofH+ Yangji Hospital
Oct 1, 2021
Hypertension Trial in Seoul (C52R1H Tab. and C52R2 Tab., AJU-C52L)
Recruiting
- Hypertension
- C52R1H Tab. and C52R2 Tab.
- AJU-C52L
-
Seoul, Republic Of South Korea, Korea, Republic ofH+ Yangji Hospital
Oct 1, 2021
Hypertension Trial in Seoul (AD-2101, AD-2102, AD-2101 + AD-2102)
Completed
- Hypertension
- AD-2101
- +2 more
-
Seoul, Korea, Republic ofKorea University Guro Hospital
Jul 20, 2021
ASCVD, Impaired Fasting Glucose, Hypertension Trial in Seongnam-si, Cheonan, Seoul (Duowell®, Monorova® + Amlopin®)
Completed
- ASCVD
- +2 more
- Duowell®
- Monorova® + Amlopin®
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +3 more
May 31, 2021
Hypercholesterolemia, Hypertension Trial in Seoul (Ezetimibe/Rosuvastatin, Telmisartan, Telmisartan/Amlodipine 80 Mg-5 Mg ORAL
Completed
- Hypercholesterolemia
- Hypertension
- Ezetimibe/Rosuvastatin
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 10, 2021
Hypertension Trial in Seoul (16 mcg / cc of norepinephrine(group N), 0.4 unit / cc of vasopressin(group V))
Recruiting
- Hypertension
- 16 mcg / cc of norepinephrine(group N)
- 0.4 unit / cc of vasopressin(group V)
-
Seoul, Korea, Republic ofDepartment of Anaesthesiology and Pain Medicine, Anaesthesia and
May 3, 2021
Hypertension, Dyslipidemia Trial in Seoul (Duowell®, Telmisartan)
Completed
- Hypertension
- Dyslipidemia
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 4, 2021